The agency recommends against using current tests to screen for the disease and relying on the test results to make treatment decisions. Instead, the FDA recommends women talk with their physicians about ways to decrease ovarian cancer risk and for physicians to refrain from using the tests. In addition, the agency said physicians should refer women at high risk for ovarian cancer to genetic counselors or gynecologic oncologists.
Current screenings may lead to false positives and unnecessary treatment, or false negatives and delayed treatment, the alert said.
More articles about healthcare quality:
NIH, HHS offer up to $20M in prizes for antibiotic resistance-combating solutions
Pennsylvania reports its 1st sexually transmitted Zika case
Glendale Adventist Medical Center’s ban on vaginal-breech deliveries sparks activist protests
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.